Results 181 to 190 of about 5,279 (205)

People also looked at

Frontiers in Medicine, 2022
Xiaosheng Yang, Weijie Zhong
exaly  

Paxlovid (nirmatrelvir/ritonavir).

WMJ : official publication of the State Medical Society of Wisconsin, 2022
Kristin, Busse, Abir T, El-Alfy
openaire   +1 more source

Postmarketing Reporting of Paxlovid-Related Dysgeusia: A Real-World Pharmacovigilance Study

Otolaryngology - Head and Neck Surgery, 2023
Ashton E Lehmann, Hans C Baertsch, Aria Jafari   +2 more
exaly  

Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer

JTO Clinical and Research Reports, 2023
Misako Nagasaka, Lee Nguyen, Sai-Hong Ignatius Ou   +2 more
exaly  

Proxalutamide for the treatment of COVID-19 rebound following Paxlovid treatment: Report of four cases and review of the literature

Journal of Clinical Laboratory Analysis, 2023
Dawei Yang
exaly  

Paxlovid for a Patient on a DOAC

2022
openaire   +1 more source

Paxlovid for a patient on DOAC

2022
openaire   +1 more source

Dosing errors common with Paxlovid

Reactions Weekly, 2022
openaire   +1 more source

Paxlovid and tacrolimus drug interaction

Reactions Weekly, 2023
openaire   +1 more source

Paxlovid: risk of drug interactions

Reactions Weekly, 2023
openaire   +1 more source